The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.
Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump's planned pharmaceutical tariffs.
Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump's planned pharmaceutical tariffs.